Med Op-Ed: Cookies Hook, Bariatric Surgery Endures, Tirzepatide Tempts
Reported by Medscape. Read the original →
The headline suggests a discussion in an op-ed format regarding the addictive nature of cookies, the ongoing relevance of bariatric surgery, and the appeal of Tirzepatide. It implies an exploration of these topics in relation to health and weight management.
Summarised by a model from Medscape's headline and its own description of the story. We did not read the article, and this is not our reporting — the link above is.
On file here
Every number below is counted from this library's own approved studies — the ones with a page you can open and check. Counts move as papers are filed.
- Clinical performance of monolithic and veneered zirconia three-unit posterior FDPs: A five-year multicenter randomized controlled trial.Human · RCT · 2026
- Insights from a double-blind, randomized, direct-to-participant intervention trial for Long COVIDHuman · RCT · 2026
- Evaluation of clinical relevance of weight nadirs and weight regain during 3 years of treatment with tirzepatide in participants with obesity or overweight and prediabetes.Human · RCT · 2026
What the headline doesn't tell you
- Tirzepatide has 29 studies on file, 16 of them in humans, the newest published 2026.
Counted, not written: each line is a sentence filled in from the study counts above. None of it is a judgement about the story or the compound.